Published in Ann Surg Treat Res on December 29, 2015
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (2013) 12.46
EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol (2011) 6.63
IL28B and the control of hepatitis C virus infection. Gastroenterology (2010) 3.02
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology (2005) 1.97
Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology (1998) 1.95
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus. Liver Transpl (2011) 1.85
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology (2005) 1.82
Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation (2013) 1.78
Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. Am J Transplant (2008) 1.70
A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology (1996) 1.65
Early high peak hepatitis C viral load levels independently predict hepatitis C-related liver failure post-liver transplantation. Liver Transpl (2009) 1.50
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49
Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. Gastroenterology (2010) 1.47
Hepatitis C virus treatment pre- and post-liver transplantation. Liver Int (2012) 1.30
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation. Aliment Pharmacol Ther (2010) 1.10
The prevalence of hepatitis C virus infection in Korea: pooled analysis. J Korean Med Sci (2005) 1.09
Are posttransplantation protocol liver biopsies useful in the long term? Liver Transpl (2001) 0.87
Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl (2012) 0.86
Hepatitis C recurrence: the Achilles heel of liver transplantation. Transpl Infect Dis (2013) 0.85
Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl (2006) 2.58
Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl (2007) 1.59
The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl (2004) 1.41
Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl (2005) 1.27
Hepatectomy of living donors with a left-sided gallbladder and multiple combined anomalies for adult-to-adult living donor liver transplantation. Liver Transpl (2004) 1.21
Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft. Liver Transpl (2006) 1.14
Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl (2006) 1.06
Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transpl Int (2010) 0.93
Reconstruction of inferior right hepatic veins in living donor liver transplantation using right liver grafts. Liver Transpl (2012) 0.93
Pediatric liver transplantation outcomes in Korea. J Korean Med Sci (2013) 0.91
Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis. Ann Surg Oncol (2013) 0.90
Hepatic vein anatomy of the medial segment for living donor liver transplantation using extended right lobe graft. Liver Transpl (2005) 0.88
A clinical assessment of mycophenolate drug monitoring after liver transplantation. Clin Transplant (2010) 0.88
Living donor liver transplantation. Curr Opin Organ Transplant (2014) 0.87
Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver. J Surg Oncol (2014) 0.86
Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy. Liver Transpl (2008) 0.86
Reappraisal of plasmapheresis as a supportive measure in a patient with hepatic failure after major hepatectomy. Case Rep Gastroenterol (2007) 0.85
Trend and outcome of Korean patients receiving overseas solid organ transplantation between 1999 and 2005. J Korean Med Sci (2010) 0.85
Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation? Liver Transpl (2011) 0.83
HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis (2007) 0.83
Cardiac tamponade caused by tuberculosis pericarditis in renal transplant recipients. J Korean Surg Soc (2011) 0.82
Pneumatosis intestinalis after adult liver transplantation. J Korean Surg Soc (2011) 0.81
Technique and outcome of autologous portal Y-graft interposition for anomalous right portal veins in living donor liver transplantation. Liver Transpl (2009) 0.80
A comparative study regarding the effect of an intraperitoneal anti-adhesive agent application in left-liver living donors. Korean J Hepatobiliary Pancreat Surg (2014) 0.80
A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients. Ann Surg Treat Res (2014) 0.80
Graft-versus-host disease after kidney transplantation. J Korean Surg Soc (2011) 0.79
Thoracoscopic repair of esophageal atresia with tracheoesophageal fistula: overcoming the learning curve. J Pediatr Surg (2014) 0.79
Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int (2012) 0.79
Fenestration of liver cysts in polycystic liver disease to improve quality of life: a case report and literature review. Korean J Hepatobiliary Pancreat Surg (2015) 0.79
Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy. JPEN J Parenter Enteral Nutr (2015) 0.79
Conjoined unification venoplasty for triple portal vein branches of right liver graft: a case report and technical refinement. Korean J Hepatobiliary Pancreat Surg (2016) 0.79
Comparison of two fluid warming devices for maintaining body core temperature during living donor liver transplantation: Level 1 H-1000 vs. Fluid Management System 2000. Korean J Anesthesiol (2014) 0.78
Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation. Clin Transplant (2009) 0.78
Feasibility of laparoscopic liver resection for giant hemangioma of greater than 6 cm in diameter. Korean J Hepatobiliary Pancreat Surg (2014) 0.78
Optimal tailored screening protocol after living donor liver transplantation for hepatocellular carcinoma. J Korean Med Sci (2014) 0.78
Application of temporary inflow control of the Glissonean pedicle method provides a safe and easy technique for totally laparoscopic hemihepatectomy by Glissonean approach. Ann Surg Treat Res (2017) 0.78
A review of current status of living donor liver transplantation. Hepatobiliary Surg Nutr (2016) 0.77
Intraoperative hyperglycemia during liver resection: predictors and association with the extent of hepatocytes injury. PLoS One (2014) 0.77
Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2014) 0.77
CDK4 amplification predicts recurrence of well-differentiated liposarcoma of the abdomen. PLoS One (2014) 0.77
Morphometric and simulation analyses of right hepatic vein reconstruction in adult living donor liver transplantation using right lobe grafts. Liver Transpl (2010) 0.77
Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A? Ann Surg Treat Res (2014) 0.77
Adeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients. Ann Lab Med (2016) 0.76
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma. Clin Mol Hepatol (2016) 0.76
Encapsulating peritoneal sclerosis in liver transplant recipients: a report of 2 cases. Ann Surg Treat Res (2017) 0.75
Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation. Hepatobiliary Surg Nutr (2016) 0.75
Incidental gallbladder cancer after routine cholecystectomy: when should we suspect it preoperatively and what are predictors of patient survival? Ann Surg Treat Res (2016) 0.75
Liver retransplantation for adult recipients. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy. Ann Hepatobiliary Pancreat Surg (2017) 0.75
Therapeutic induction of hepatic atrophy for isolated injury of the right posterior sectoral duct following laparoscopic cholecystectomy. Korean J Hepatobiliary Pancreat Surg (2011) 0.75
Fibrin glue-infiltrating hemostasis for intractable bleeding from the liver or spleen during liver transplantation. Ann Hepatobiliary Pancreat Surg (2016) 0.75
Long-term outcome of ischemic type biliary stricture after interventional treatment in liver living donors: a report of two cases. Korean J Hepatobiliary Pancreat Surg (2015) 0.75
Protrusion of hepatocellular carcinoma is a predictor of early recurrence in hepatectomy patients after spontaneous rupture. Ann Surg Treat Res (2016) 0.75
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection. Clin Mol Hepatol (2016) 0.75
Living donor liver transplantation for patients with alcoholic liver disease. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients. Korean J Hepatobiliary Pancreat Surg (2015) 0.75
Primary hepatic neuroendocrine carcinoma. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
Standardized surgical techniques for adult living donor liver transplantation using a modified right lobe graft: a video presentation from bench to reperfusion. Korean J Hepatobiliary Pancreat Surg (2016) 0.75
Assessment of right liver graft perfusion effectiveness between one and two-catheter infusion methods. Korean J Hepatobiliary Pancreat Surg (2014) 0.75
Effect of early enteral nutrition after hepatectomy in hepatocellular carcinoma patients. Korean J Hepatobiliary Pancreat Surg (2012) 0.75
Technical knacks and outcomes of extended extrahepatic bile duct resection in patients with mid bile duct cancer. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients. Ann Surg Treat Res (2014) 0.75